Hans G. Nilsson
Director/Board Member at PharmNovo AB
Profile
Hans G.
Nilsson is currently the Director at PharmNovo AB since 2018.
Prior to this, he was the President at AstraZeneca R&D Boston, Inc.
Hans G. Nilsson active positions
Companies | Position | Start |
---|---|---|
PharmNovo AB
PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden. | Director/Board Member | 2017-12-31 |
Former positions of Hans G. Nilsson
Companies | Position | End |
---|---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | Health Technology |
PharmNovo AB
PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Hans G. Nilsson